APC
PFE icon

Aspire Private Capital’s Pfizer PFE Stock Holding History

Aspire Private Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,629
Closed -$76.1K – 493
2024
Q3 		$76.1K Sell
2,629
-122
-4% -$3.56K 0.02% 210
2024
Q2 		$77K Sell
2,751
-92
-3% -$2.53K 0.02% 208
2024
Q1 		$78.9K Buy
2,843
+210
+8% +$5.83K 0.02% 208
2023
Q4 		$75.8K Sell
2,633
-133
-5% -$4.02K 0.02% 203
2023
Q3 		$91.8K Buy
2,766
+91
+3% +$3.22K 0.03% 167
2023
Q2 		$98.1K Sell
2,675
-41
-2% -$1.6K 0.03% 157
2023
Q1 		$111K Sell
2,716
-240
-8% -$10.4K 0.04% 154
2022
Q4 		$151K Sell
2,956
-100
-3% -$4.79K 0.05% 139
2022
Q3 		$134K Sell
3,056
-126
-4% -$6.12K 0.05% 140
2022
Q2 		$167K Sell
3,182
-51
-2% -$2.6K 0.06% 130
2022
Q1 		$167K Sell
3,233
-706
-18% -$36.6K 0.05% 141
2021
Q4 		$233K Sell
3,939
-658
-14% -$32.6K 0.07% 133
2021
Q3 		$198K Sell
4,597
-470
-9% -$20.8K 0.07% 136
2021
Q2 		$198K Sell
5,067
-5,119
-50% -$199K 0.06% 141
2021
Q1 		$369K Sell
10,186
-5,559
-35% -$197K 0.13% 85
2020
Q4 		$580K Sell
15,745
-1,046
-6% -$38.4K 0.22% 69
2020
Q3 		$585K Sell
16,791
-268
-2% -$9.4K 0.24% 64
2020
Q2 		$529K Buy
17,059
+267
+2% +$9.07K 0.25% 59
2020
Q1 		$520K Sell
16,792
-3,917
-19% -$133K 0.28% 55
2019
Q4 		$770K Buy
20,709
+8,028
+63% +$286K 0.33% 57
2019
Q3 		$432K Buy
12,681
+6,881
+119% +$250K 0.21% 75
2019
Q2 		$238K Buy
5,800
+2,582
+80% +$103K 0.11% 101
2019
Q1 		$130K Sell
3,218
-118
-4% -$4.73K 0.07% 150
2018
Q4 		$138K Buy
+3,336
New +$138K 0.08% 131

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspire Private Capital's PFE Position: Q4 2024 in Review

Aspire Private Capital sold out of Pfizer (PFE) in Q4 2024, closing a stake of 2,629 shares — an estimated $76.1K sold.

Aspire Private Capital first reported a position in PFE in Q4 2018 and held it in 24 quarters. The position peaked at $770K in Q4 2019. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Aspire Private Capital reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 2,629 Pfizer shares in Q4 2024, an estimated $76.1K.
  • Aspire Private Capital first reported a position in Pfizer in Q4 2018 and held it in 24 quarters.
  • Aspire Private Capital's Pfizer position peaked at $770K in Q4 2019.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.